Health Visitor Service Delivery Metrics: Quarter 1 2018/19 Statistical Commentary (October 2018 release) – Public Health England

Local authority commissioners and health professionals can use these resources to track how many pregnant women, children and families in their local area have received health promoting reviews at particular points during pregnancy and childhood. The data and commentaries also

Child development outcomes at 2 – 2½ years Quarter 1 2018/19 Statistical Commentary (October 2018 release) – Public Health England

Local authority commissioners and health professionals can use these resources to track to what extent children aged 2 to 2 and a half years in their local area are achieving the expected levels of development.  The data is collected from

Official Statistics: Child development outcomes at 2 – 2½ years (Experimental Statistics): Quarter 2 2018/19 Statistical Commentary (January 2019) – Public Health England

Local authority commissioners and health professionals can use these resources to track to what extent children aged 2 to 2 and a half years in their local area are achieving the expected levels of development.  The data is collected from

Official Statistics: Child development outcomes at 2 – 2½ years (Experimental Statistics): Quarter 3 2018/19 Statistical Commentary (July 2019) – Public Health England

Local authority commissioners and health professionals can use these resources to track to what extent children aged 2 to 2 and a half years in their local area are achieving the expected levels of development.  The data is collected from

Official Statistics: Child development outcomes at 2 – 2½ years (Experimental Statistics): Quarter 4 2018/19 Statistical Commentary (July 2019) – Public Health England

Local authority commissioners and health professionals can use these resources to track to what extent children aged 2 to 2 and a half years in their local area are achieving the expected levels of development.  The data is collected from

Proton Beam Therapy for Oesophageal Cancer: Engagement Report for Clinical Commissioning Policies – NHS England and NHS Improvement

NHS England has reviewed the evidence to treat oesophageal cancer with proton beam therapy (PBT) in adults and have concluded that there is not enough evidence to make the treatment available through routine commissioning.

Proton Beam Therapy for Oesophageal Cancer: Policy Statement – NHS England and NHS Improvement

NHS England has reviewed the evidence to treat oesophageal cancer with proton beam therapy (PBT) in adults and have concluded that there is not enough evidence to make the treatment available through routine commissioning.

Proton Beam Therapy for Head and Neck Cancer in Adults: Clinical Panel Report – NHS England and NHS Improvement

The Panel discussed the range of diagnoses which fit within head and neck cancer. The Panel noted that the skull based tumours considered as part of the previous policy were excluded, which included chondrosarcoma and chordoma. At this stage the

Proton Beam Therapy for Head and Neck Cancer in Adults: Clinical Priorities Advisory Group – NHS England and NHS Improvement

This policy statement recommends that proton beam therapy (PBT), a form of radiotherapy, should not be made routinely available for the treatment of head and neck cancer in adults. This treatment is not currently available in this indication and therefore

Proton Beam Therapy for Head and Neck Cancer in Adults: Engagement Report for Clinical Commissioning Policies – NHS England and NHS Improvement

NHS England has reviewed the evidence to treat head and neck cancer in adults with proton beam therapy and have concluded that there is not enough evidence to make the treatment available through routine commissioning. This excludes any routinely commissioned

Proton Beam Therapy for Head and Neck Cancer in Adults Policy Statement – NHS England and NHS Improvement

NHS England has reviewed the evidence to treat head and neck cancer in adults with proton beam therapy and have concluded that there is not enough evidence to make the treatment available through routine commissioning. This excludes any routinely commissioned

Proton beam therapy for adult lymphoma: Clinical Panel Report – NHS England and NHS Improvement

The Panel discussed the range of diagnoses which fit within head and neck cancer. The Panel noted that the skull based tumours considered as part of the previous policy were excluded, which included chondrosarcoma and chordoma. At this stage the

Clinical Commissioning Policy Statement Proton Beam Therapy for Hepatocellular Carcinoma: Engagement Report for Clinical Commissioning Policies – NHS England and NHS Improvement

NHS England has reviewed the evidence to treat hepatocellular carcinoma (HCC) with proton beam therapy (PBT) and have concluded that there is not enough evidence to make the treatment available through routine commissioning.

Proton Beam Therapy for for Hepatocellular Carcinoma Policy Statement – NHS England and NHS Improvement

NHS England has reviewed the evidence to treat hepatocellular carcinoma (HCC) with proton beam therapy (PBT) and have concluded that there is not enough evidence to make the treatment available through routine commissioning.

Complex Gynaecology: Congenital Gynaecological Anomalies (Children of 13 years and above and Adults) – NHS England and NHS Improvement

This service specification covers the provision of specialised, multi-disciplinary team  gynaecological management, including surgery in some cases, for girls from 13 years of age and women with rare, congenital anomalies of the female genital tract. In a small number of

Health, care and the 100-year life: How policymakers can ensure health and fairness for all in an era of extreme longevity – Social Market Foundation

A child born today has a one in three chance of living to 100. Increased longevity should be celebrated. However, it will bring a range of challenges for society. This is the first in a series of reports focusing on

Carers Action Plan 2018 – 2020: Supporting carers today: One-year on progress review – Department of Health and Social Care

The 1-year progress report highlights the progress that has been made in delivering the carers action plan 2018 to 2020 to increase support for carers.  The cross-government action plan was published in June 2018. It sets out the government’s commitment to

PSNC Briefing 029/19: The Pharmacy Quality Scheme 2019/20 – Pharmaceutical Services Negotiating Committee

Pharmaceutical Services Negotiating Committee services and commissioning bulleting that details that in July 2019, a new Pharmacy Quality Scheme (PQS) was announced for the 2019/20 financial year; this scheme was formerly known as the Quality Payments Scheme (QPS). The new

Information on the community pharmacy contract settlement and funding for 2019/2020 to 2023/24 – Pharmaceutical Services Negotiating Committee

Pharmaceutical Services Negotiating Committee funding and statistics briefing that sets out the main elements of the five-year community pharmacy funding settlement for 2019/20 to 2023/24 and gives background information on what the announcement means and how community pharmacy funding works.

The Community Pharmacy Contractual Framework for 2019/20 to 2023/24: supporting delivery for the NHS Long Term Plan – Department of Health and Social Care

The new contractual arrangements will come into force from 1 October 2019 and will help to deliver the ambitions set out in the NHS Long Term Plan.  It presents a 5-year deal setting out how community pharmacy will support delivery of